Skip to Main Content

MEDCAC Meeting 11/4/2004 - Bariatric Surgery for Treatment of Morbid Obesity

Select the ’Print Record’, ‘Add to Basket’ or ‘Email Record’ buttons to print the record, to add it to your basket or to email the record.
  • Expand All
  • Collapse All

Morbid obesity is recognized as a significant health risk associated with physical problems that may increase morbidity and mortality among the Medicare population.   According to the U.S. Preventive Services Task Force, “obesity is a risk factor for major causes of death, including cardiovascular disease, numerous types of cancer, and diabetes, and is linked with markedly diminished life expectancy.” The surgical management of morbid obesity, bariatric surgery, is a treatment that may result in dramatic weight loss.  Several different surgical procedures have been used for people with morbid obesity, including biliopancreatic diversion, Roux-en-Y gastric bypass, and gastric banding. 

The Agency for Health Research and Quality (AHRQ) recently issued a technology assessment entitled: Pharmacological and Surgical Treatment of Obesity.  Evidence Report/Technology Assessment No. 103.*   This, along with numerous other publications, indicate the need for a careful assessment of the evidence surrounding bariatric surgery.

CMS is referring the issue of surgical management of obesity to the Medicare Coverage Advisory Committee (MCAC).   The MCAC will review the evidence related to the benefits, risks and costs of bariatric surgery in obesity.

Notice of this action is given under the Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)(1) and (a)(2)).

This tracking sheet does not represent a National Coverage Analysis for bariatric surgery.  It only serves to announce the upcoming MCAC meeting. 

 

*Shekelle PG, Morton SC, Maglione MA, Suttorp M, Tu W, Li Z, Maggard M, Mojica WA, Shugarman L, Solomon V, Jungvig L, Newberry SJ, Mead D, Rhodes S. Pharmacological and Surgical Treatment of Obesity. Evidence Report/Technology Assessment No. 103 (Prepared by the Southern California - RAND Evidence-Based Practice Center, Santa Monica, CA, under contract Number 290-02-0003.) AHRQ Publication No. 04-E028-2. Rockville, MD: Agency for Healthcare Research and Quality. July 2004.
September 2, 2004 A Medicare Coverage Advisory Committee meeting will be held on Thursday, November 4, 2004, from 7:30 a.m. until 4:30 p.m. EST at the Holiday Inn Inner Harbor, 301 West Lombard Street, Baltimore, MD 21201. The Committee will review the evidence related to the benefits, risks and costs of bariatric surgery in obesity. Formal announcement of this meeting in the Federal Register will be forthcoming. Questions to be addressed to the MCAC panel will be posted soon.
October 5, 2004 Publication of the Federal Register notice [PDF, 71KB] of the meeting and release of the questions [PDF, 98KB] to be addressed to the MCAC panel. Due to the late posting of the questions, the deadline for receiving public comments has been extended to close of business on October 14, 2004. Individuals wishing to make scheduled public comments should ensure that their presentations focus on these questions.
October 21, 2004 CMS is interested in the public's comment on the potential creation of a national registry for Medicare patients undergoing bariatric surgery. We encourage that discussion at the MCAC.
October 26, 2004 Additional information is available including the agenda, speaker list, and roster .
November 3, 2004 CMS is posting its summary of evidence  [PDF, 1MB] on bariatric surgery.
February 7, 2005 CMS is posting the transcript  [PDF, 1MB]  of the November 4 meeting.
Federal Register Notice
Medicare Coverage Advisory Committee
November 4, 2004
7:30 AM – 4:30 PM
Holiday Inn Inner Harbor
Agenda
Ronald M. Davis, MD, Chairperson
Barbara J. McNeil, MD, PhD, Vice-Chairperson
Steve Phurrough, MD, MPA, Coverage and Analysis Group
Kimberly Long, Executive Secretary
7:30 – 8:00 AM Registration
8:00 – 8:15 AM Opening Remarks—K.Long / S. Phurrough, MD, MPA/R. Davis, MD
8:15 – 8:55 AM CMS Summary of Evidence and Presentation of Voting Questions:
Ross Brechner, MD, MS, MPH
8:55 – 9:45 AM Scheduled Public Comments
(Refer to Speaker List)
Public attendees, who have contacted the executive secretary prior to the meeting, will address the panel and present information relevant to the agenda. Speakers are asked to state whether or not they have any financial involvement with manufacturers of any products being discussed or with their competitors and who funded their travel to this meeting.
9:45 – 10:00 AM BREAK
10:00 – 11:00 AM Scheduled Public Comments (continued)
11:00 – 11:30 AM Questions to Presenters
11:30 – 12:00 AM Open Public Comments
Public Attendees who wish to address the panel will be given that opportunity
*    *    *    *    *    *    *    *    *    *    *    *  
12:00 – 1:00PM LUNCH (on your own)
*    *    *    *    *    *    *    *    *    *    *    *  
1:00 – 4:15 PM Open Panel Deliberations: Dr. Davis
  • Formal Remarks and Vote
    The Chairperson will ask each panel member to state his or her position on the voting questions
4:15 – 4:30 PM Closing Remarks / Adjournment: K. Long /Dr. Phurrough
4:30 PM ADJOURN

Download Minutes [PDF, 293KB].

Download Qs and As [PDF, 98KB].
Chairperson Consumer Representative:
Ronald M. Davis, MD Nancy Loving
Center for Health Promotion and WomenHeart: The National Coalition for
Disease Prevention Women with Heart Disease
Henry Ford Health System  
   
Vice-Chairperson Industry Representative:
Barbara J. McNeil, MD, PhDG. Gregory Raab, PhD
Harvard Medical School Raab & Associates, Inc.
   
Voting Members Guest Panelists
David J. Margolis, MD, PhD Madison Powers, JD, DPhil
Department of Dermatology Georgetown University
Hospital of the University of Pennsylvania  
  Sam Klein, MD, MS
Clifford Goodman, PhD Department of Internal Medicine,
The Lewin Group Washington University
   
Brent J. O’Connell, MD Henry Buchwald, MD, PhD
High Mark Blue Shield University of Minnesota
   
Jonathan P. Weiner, PhD Harvey Sugerman, MD
Division of Health Services Research, American Society of Bariatric Surgeons
Johns Hopkins School of Public Health  
  CMS Liaison
Jed Weissberg, MD Steve E. Phurrough, MD, MPA
The Permanente Federation LLC Director, Coverage and Analysis Group
  Centers for Medicare & Medicaid Services
Michael Abecaassis, MD  
Division of Organ Transplantation Executive Secretary
Northwestern Memorial Hospital Kimberly Long
  Centers for Medicare & Medicaid Services
Kieren P. Knapp, DO  
Jacobus Medical Center
   
William F. Owen, Jr., MD  
Duke University  
8:55 – 9:45 AM Walter Pories, MD, et al.
  • John G. Kral, MD, PhD, FACS
  • Nicolas V. Christou, MD, PhD
  • David R. Flum, MD, MPH
  • Bruce Wolfe, MD
  • Philip R. Schauer, MD
  • Michel Gagner, MD
  • Christine J. Ren, MD
  • Thomas Wadden, MD
  • Sasha Stiles, MD
  • Col. Robert Stratiff
  • Mrs. Stella Tanner
10:00 – 10:04 AM American Dietetic Association
Mary H. Hager, PhD, RD, FADA
10:04 – 10:08 AM American College of Surgeons
Josef E. Fischer, MD, FACS
10:08 – 10:12 AM John B. Dixon, MBBS, PhD
Monash University, Australia
10:12 – 10:16 AM Jeff W. Allen, MD, FACS
University of Louisville, Dept. of Surgery
10:16 – 10:20 AM David Provost, MD
University of Texas Southwestern Medical Center at Dallas
10:20 – 10:24 AM Barry L. Fisher, MD, FACS
University of Nevada School of Medicine
10:24 – 10:28 AM Douglas S. Hess, MD
Private Practice; Bowling Green, OH
10:28- 10:32 AM Robin Blackstone, MD, FACS
Scottsdale Bariatric Center
10:32- 10:36 AM Marc Bessler, MD
New York Presbyterian Center for Obesity Surgery,
Columbia University
10:36- 10:40 AM Christopher D. Still, DO, FACN, FACP
Geisinger Health System
10:40- 10:44 AM Karen Schoelles, MD
MetaWorks, Inc.
10:44- 10:48 AM Robert A. Rabkin, MD, FACS
Pacific Laparoscopy, San Francisco
10:48 10:52 AM Sondra Albers, Patient
10:52 10:56 AM Pamela Rogers, Patient
10:56 – 11:00 AM Eldith Willis, Patient
92